Sunday, May 19, 2024
wellness India Expo
Home Tags APAC


Diatron enters Indian market, announces 2024 reagent manufacturing plans

This strategic move highlights Diatron's commitment to strengthening its presence in Asia & to providing its services to both existing & new customers in the Asia-Pacific (APAC) region

Urgent investment & action needed in Asia Pacific to meet WHO’s...

Newly launched Asia Pacific Women’s Cancer Coalition (APAC WCC) calls for a greater commitment to address the gaps to support countries in achieving their national targets for cancer prevention and control

India’s rise to global vaccine triumph: A journey of excellence &...

India's rich history with vaccines is a testament to the country's commitment to global health

Insulin pumps market to hit US$ 13.34 billion by 2032

The Asia Pacific market is expected to rise at a high CAGR during the forecast period due to developing healthcare facilities

NAFLD clinical trial activity catching up in China, mostly driven by...

China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade

Pratima Reddy is the new Managing Director of Merck Specialities

Pratima will lead India's healthcare strategy and operations, effective August 1, 2022, as successor to Anandram Narasimhan, transitioning into a regional role at APAC

Medtronic announces first of its kind regional open innovation challenge platform...

Proposed investment of US$50 million to foster MedTech innovation in APAC

Aetna India appoints Anurag Khosla as CEO

His appointment is a strategic move for Aetna India to build on the success of the last few years and continue to develop the company. It also aims to strengthen their leading position in the Indian preventive and primary care service market...................

US-China trade war offers window of opportunity for Indian pharma sector

As per the leading data and analytics company GlobalData, the standoff between China and India over regulatory issues provides great opportunity for the Indian pharma firms to penetrate the Chinese healthcare market and reduce trade deficit...………..

Aplagon partners with Cadila to develop & test antithrombotic products in...

Aplagon has partnered with Cadila Pharmaceuticals to develop and commercialize APAC First-in-Class antithrombotics for the prevention of blood vessel occlusions related to vascular interventions..........